Homology Medicines, Inc.
NASDAQ:FIXX
Overview | Financials
Company Name | Homology Medicines, Inc. |
Symbol | FIXX |
Currency | USD |
Price | 0.935 |
Market Cap | 3,018,745 |
Dividend Yield | 0% |
52-week-range | 0.9 - 26.64 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Albert Seymour Ph.D. |
Website | https://www.homologymedicines.com |
An error occurred while fetching data.
About Homology Medicines, Inc.
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD